Oxidative stress mediates monocrotaline-induced alterations in tenascin expression in pulmonary artery endothelial cells
- PMID: 9251245
- DOI: 10.1016/s1357-2725(97)00010-1
Oxidative stress mediates monocrotaline-induced alterations in tenascin expression in pulmonary artery endothelial cells
Abstract
Oxidative stress may be involved in monocrotaline (MCT)-induced endothelial cell injury and upregulation of extracellular matrix proteins in the pulmonary vasculature. To test this hypothesis, cytotoxicity, expression and distribution of tenascin (TN) as well as cellular oxidation were determined in porcine pulmonary artery endothelial cells (PAECs) exposed to MCT and/or to an oxygen radical scavenger, dimethylthiourea (DMTU). Relative to controls, treatment with 2.5 mM MCT for 24 hr produced cytotoxicity as evidenced by changes in cellular morphology, cell detachment, hypertrophy, reduction in cellular proliferation and severe cytoplasmic vacuolization. Parallel studies showed that MCT markedly altered the expression and distribution of TN in PAEC as determined by immunocytochemistry. Western analysis showed that MCT increased cellular TN content and promoted the appearance of an additional, smaller TN isoform. Northern analysis demonstrated an increase in the steady-state level of TN-specific mRNA in response to MCT treatment. Exposure to MCT also increased the synthesis of cell-associated and media-associated TN as determined by immunoprecipitation. In addition, MCT increased the intensity of cellular oxidative stress as measured by 2,7-dichlorofluorescein fluorescence. Co-treatment with DMTU prevented MCT-induced cytotoxicity, alterations in TN distribution and content, and reduced the increase in DCF fluorescence. These results suggest that MCT-induced cytotoxicity and upregulation of TN are mediated, at least in part, by induction of cellular oxidative stress.
Similar articles
-
Polyamine regulatory processes and oxidative stress in monocrotaline-treated pulmonary artery endothelial cells.Cell Biol Int. 1997 Dec;21(12):801-12. doi: 10.1006/cbir.1997.0200. Cell Biol Int. 1997. PMID: 9812344
-
Tenascin synthesis, deposition, and isoforms in monocrotaline-induced pulmonary hypertensive rat lungs.Am J Physiol. 1996 Aug;271(2 Pt 1):L208-15. doi: 10.1152/ajplung.1996.271.2.L208. Am J Physiol. 1996. PMID: 8770058
-
Reactive oxygen species and substance P in monocrotaline-induced pulmonary hypertension.Toxicol Appl Pharmacol. 2001 Mar 15;171(3):165-73. doi: 10.1006/taap.2000.9117. Toxicol Appl Pharmacol. 2001. PMID: 11243916
-
Lung vascular injury from monocrotaline pyrrole, a putative hepatic metabolite.Adv Exp Med Biol. 1991;283:477-87. doi: 10.1007/978-1-4684-5877-0_64. Adv Exp Med Biol. 1991. PMID: 1906225 Review.
-
Chronic pulmonary hypertension--the monocrotaline model and involvement of the hemostatic system.J Toxicol Environ Health B Crit Rev. 1998 Oct-Dec;1(4):271-346. doi: 10.1080/10937409809524557. J Toxicol Environ Health B Crit Rev. 1998. PMID: 9776954 Review.
Cited by
-
Protection of oral hydrogen water as an antioxidant on pulmonary hypertension.Mol Biol Rep. 2013 Sep;40(9):5513-21. doi: 10.1007/s11033-013-2653-9. Epub 2013 Aug 18. Mol Biol Rep. 2013. PMID: 23955545 Free PMC article.
-
Role of oxidative stress versus lipids in monocrotaline-induced pulmonary hypertension and right heart failure.Physiol Rep. 2021 Nov;9(22):e15090. doi: 10.14814/phy2.15090. Physiol Rep. 2021. PMID: 34816616 Free PMC article.
-
Monocrotaline Induces Endothelial Injury and Pulmonary Hypertension by Targeting the Extracellular Calcium-Sensing Receptor.J Am Heart Assoc. 2017 Mar 22;6(4):e004865. doi: 10.1161/JAHA.116.004865. J Am Heart Assoc. 2017. PMID: 28330842 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
